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The present study aimed at exploring the relations between body mass index (BMI, (weight in kilograms)/(height in meters)
2) and
stature and cancer of the small intestine (1162 cases) in a large Norwegian cohort (of two million) with measured height and weight.
Elevated BMI in males and increasing height in both sexes were associated with a moderately increased risk of cancer of the small
intestine.
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Overweight or obesity has been linked to an increased risk of
several site-specific cancers, including colorectal cancers
(Engeland et al, 2005). A large cohort study of male US veterans
found a significant excess risk of small intestine cancer, especially
of the duodenum, among obese white veterans (Samanic et al,
2004). Also, a recent cohort study of obese individuals in Sweden
reported a significantly elevated risk of cancer of the small
intestine, but only among men (Wolk et al, 2001).
The aim of the present study was to explore the associations
between body mass index (BMI) and height and the risk of cancers
of the small intestine in a very large Norwegian cohort of both men
and women with a long follow-up.
STUDY POPULATION
The study population has been described in detail elsewhere,
(Engeland et al, 2004).Briefly in a series of health surveys during
1963–2001, height and weight were measured in a standardised
way by a trained staff in 2001727 persons (963709 men and
1038018 women) aged 20–74 years. Deaths, emigrations and
cases of cancer of the small intestine (International Classification
of Diseases, seventh revision (ICD-7): 152) in this cohort were
identified by linkage to the Death Registry at Statistics Norway
(Statistics Norway, 2005) and to the Cancer Registry of Norway
(The Cancer Registry of Norway, 2005). Both these registries are
population based and are covering the entire Norwegian popula-
tion. A unique 11-digit identification number assigned to all
individuals living in Norway after 1960 simplified the linkages.
In the present study, only histologically verified cancers of the
small intestine were included. Persons with a diagnosis of cancer of
the small intestine, prior to the height and weight measurements,
were excluded. Consequently, 32 persons were excluded in the
analyses. In the analyses, the persons in the cohort were followed
up from the date of measurement until the date of cancer
diagnosis, emigration, age 100 years, death or until 31 December
2003. Altogether, 2001695 persons were eligible for the study.
A small number of these (39 men and 32 women) were lost to
follow-up.
STATISTICAL METHODS
Cox’s proportional-hazards regression models (Cox and Oakes,
1984), with time since measurement as the time variable, were
fitted to obtain relative risk (RR) estimates of cancer. In the
analyses, categorised variables for age at measurement, year of
birth, BMI ((weight in kilograms)/(height in meters)
2) and height
were included. BMI was categorised using the WHO categorisation
(World Health Organization Consultation on Obesity, 1998): BMI
o18.5 (underweight), 18.5–24.9 (normal), 25.0–29.9 (preobese/
overweight) and X30.0 (obese).
Analyses were performed including BMI and height, respec-
tively, as continuous variables to test for trend in the risk of cancer
of the small intestine by BMI and height.
Separate analyses were performed for cancer at subsites of the
small intestine and for different histologies. Lymphomas were not
included in the total number of cases in the present study.
All these analyses were performed with the statistical program
package SPSS (SPSS Inc., 2001). The results were presented as RR
of cancer with 95% confidence intervals (CI).
RESULTS
The 2001624 persons (963655 men and 1037969 women)
included in this study were followed for on average 23 years
(range 0–41), constituting 47 million person-years (Table 1). The
mean age at measurement was 44 years. The proportions of
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yunderweight were 0.7 and 2.0% in men and women, respectively,
while the proportions of obese were 6 and 13%. During follow-up,
1162 cases of small intestine cancer were diagnosed among the
study subjects. The mean age at diagnosis was 68 years, and the
cases were measured on average 20 years prior to diagnosis. Of
all small intestine cancer cases, 50% were carcinoids and 35% were
adenocarcinomas.
An increase in small intestine cancer risk was seen with
increasing BMI in men and with increasing height in both sexes
(Table 2). The RR associated with a one-unit increase in BMI was
1.03 (95% CI: 1.01–1.06) in men. The RR associated with a 10cm
increase in height was 20% (95% CI: 5–37%) in men and 20%
(95% CI: 4–39%) in women. A tendency towards an increase in
risk with increasing BMI was seen for cancers of the duodenum in
both sexes. Compared with men with normal BMI, overweight and
obese men had an RR of carcinoids of 1.36 (95% CI: 1.07–1.74)
and 1.63 (95% CI: 1.01–2.65), respectively. The risk of carcinoids
increased with increasing height in both sexes. The RR associated
with a 10cm increase in height was 22% (95% CI: 1–47%) in men
and 36% (95% CI: 11–68%) in women.
To exclude the possibility that at the time of BMI measurement
weight was influenced by the presence of an undiagnosed small
intestine cancer, we analysed the data after omitting the first
5 years of follow-up. Similar results were found.
DISCUSSION
In the present study, a Norwegian cohort of more than two million
men and women was followed prospectively with regard to the risk
of small intestine cancer for an average of 23 years. More than 1150
cancer cases were observed, and the risk increased with BMI in
men and with height in both sexes.
Our study subjects were recruited from population-based
studies with high attendance, and the measurements were
performed in a standardised way. Use of a unique identification
number and population-based registries on deaths, emigrations
and cancer incidence ascertained an almost complete follow-up of
the study subjects (2001624 persons). Only 71 persons were lost to
follow-up. By the end of follow-up, 60% of the persons were alive
without a diagnosis of small intestine cancer, 40% were dead and
0.1% had small intestine cancer.
Large prospective studies have shown a significant association
between obesity and several cancers (Bianchini et al, 2002; Calle
Table 1 Number of observed cases of small intestine cancer, person-years and overall incidence rates
Men Women
Variable No. of cases Person-years Incidence rate
a No. of cases Person-years Incidence rate
a
Time since measurement
0–4 42 4704799 1 36 5104845 1
5–9 55 4186615 1 62 4630922 1
10–14 84 3539359 2 78 4042558 2
15–19 77 2974592 3 97 3554864 3
20–24 107 2514913 4 92 3134983 3
25–29 101 2100174 5 108 2716707 4
X30 105 1538398 7 118 2159852 5
Age at measurement
20–29 45 4858466 1 50 5599610 1
30–39 102 4647809 2 106 5282390 2
40–49 182 6530026 3 170 7043688 2
50–59 157 3458166 5 155 4467454 3
60–69 72 1703355 4 97 2423560 4
70–74 13 361029 4 13 528029 2
Year of birth
o1900 17 468357 4 19 686032 3
1900–1909 67 1775881 4 94 2555664 4
1910–1919 157 3514584 4 161 4554801 4
1920–1929 177 4995227 4 156 5576162 3
1930–1939 91 4317744 2 97 4836647 2
1940–1949 48 4646655 1 52 5114247 1
X1950 14 1840403 1 12 2021176 1
BMI (kg/m
2)
o18.5 4 138630 3 10 549699 2
18.5–24.9 281 12576460 2 301 14439090 2
25.0–29.9 247 7840365 3 196 7436780 3
X30.0 39 1003396 4 84 2919162 3
Height (cm)
b
o150 9 367010 2
o160/150–159 2 143607 1 177 7051248 3
160–169 102 3323991 3 328 14611055 2
170–179/X170 307 11763593 3 77 3315417 2
X180 160 6327660 3
Total 571 21558851 3 591 25344730 2
aNumber of cases of small intestine cancer per 100000 person-years.
bSplit categories pertain to men and women, respectively.
BMI in relation to cancer of the small intestine
T Bjørge et al
808












yet al, 2003). The International Agency for Research on Cancer has
classified the evidence of a causal link as ‘sufficient’ for cancers of
the colon, postmenopausal breast cancer, endometrial cancer,
renal cell carcinoma and adenocarcinoma of the oesophagus
(IARC Working Group on the Evaluation of Cancer-Preventive
Strategies, 2002). We have previously, in the present data set,
reported on a positive association between BMI and several
site-specific cancers, including colorectal cancer (Engeland et al,
2005). In the present study, an increase in the risk of small intestine
cancer was seen in men, and there was a tendency towards an
increased risk of cancers of the duodenum in both sexes.
Very few studies have examined the association between body
weight and less common cancers, such as cancer of the small
intestine. A prospective study of obesity and cancer risk in Sweden
showed a significant risk elevation for cancers of the small
intestine compared with the expected number of cases (SIR¼2.8,
95% CI¼1.6–4.5). The excess risk was restricted to males (Wolk
et al, 2001). The number of observed cases, however, was small
(nine male and eight female cases). A cohort study of military
veterans in the United States revealed a significant excess of small
intestine cancer among obese compared with those not identified
as obese (Samanic et al, 2004). The excess risk was only observed
among white veterans, and was most pronounced for the
duodenum.
A relatively large case–control study (430 cases) on risk factors
for small intestine cancer found no association between BMI
and cancer of the small intestine (Chow et al, 1993). Further, data
from two Italian hospital-based case–control studies suggested an
inverse relationship (Negri et al, 1999). However, only 23 cases
were examined.
Cancer of the small intestine is rare, and relatively little is
known about its aetiology. Risk factors for small bowel
cancer, however, include dietary factors, cigarette smoking, alcohol
intake and different medical conditions (Neugut et al, 1998).
Further, adenocarcinomas of the small and large bowel share
several common features, and it has been shown that there is a
strong similarity between the dietary correlates of risk of
adenocarcinoma of the small intestine and colon cancer (Negri
et al, 1999).
BMI has been associated with an increased risk of colon cancer,
most pronounced among men. It has been suggested that there is
an effect of factors related to adiposity on the promotion of colon
cancer, and a possible counteracting effect on these factors by
estrogens (IARC Working Group on the Evaluation of Cancer-
Preventive Strategies, 2002). Similar mechanisms might be
involved in the aetiology of small intestine cancer, in particular
adenocarcinomas of the small intestine.
In the present study, there was an increase in small intestine
cancer risk with increasing height. Very few studies have had
the possibility to examine the association between height and
small intestine cancer risk. A large number of studies have,
however, reported on a positive association between height and
cancer risk at different other sites, for instance, colorectal cancer,
prostate cancer and breast cancer (Gunnell et al, 2001). The
associations reported have been relatively weak – the tallest
individuals have been at a 20–60% increased risk compared
with the shortest. The association has been explained by genes
or by prenatal/childhood exposures. It has, however, also been
demonstrated that raised levels of insulin-like growth factor 1 are
associated with increased risk of different cancers (Gunnell et al,
2001).
In summary, in this large Norwegian cohort, the risk of cancer
of the small intestine increased with BMI in males, and with height
in both sexes. However, the increases in risk were modest.
Table 2 Relative risk (RR) of cancer of the small intestine with 95% confidence intervals (CI) obtained in Cox’s regression analyses; age at measurement
and birth cohort were included in the model in addition to either body mass index (BMI) or height
Cancer of the duodenum Cancer of the small intestine
RR 95% CI RR 95% CI
Men 118 cases 571 cases
BMI (kg/m
2)
o18.5 0.00 0.00- 1.53 0.57–4.11
18.5–24.9 1.00 Referent 1.00 Referent
25.0–29.9 1.18 0.80–1.72 1.22 1.03–1.45




o160 1.03 0.14–7.50 0.45 0.11–1.83
160–169 0.99 0.60–1.61 0.99 0.79–1.25
170–179 1.00 Referent 1.00 Referent
X180 1.04 0.69–1.62 1.23 1.01–1.50
Test for trend
a P¼0.7 P¼0.01
Women 112 cases 591 cases
BMI (kg/m
2)
o18.5 0.78 0.11–5.65 1.20 0.64–2.25
18.5–24.9 1.00 Referent 1.00 Referent
25.0–29.9 1.10 0.71–1.70 0.94 0.78–1.13




o150 0.00 0.00- 0.82 0.42–1.61
150–159 0.94 0.62–1.44 0.91 0.75–1.09
160–169 1.00 Referent 1.00 Referent
X170 1.33 0.74–2.39 1.35 1.05–1.74
Test for trend
a P¼0.4 P¼0.01
aBMI and height, respectively, were included as continuous variables.
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